This is a study to develop methods of diagnosing chronic traumatic encephalopathy (CTE) during life, as well as to examine possible risk factors for this neurodegenerative disease. One component of this study is the use of an investigational PET scan radio tracer to detect abnormal tau protein in the brain.
Age range
45 Years – 74 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Neuroimaging Positron Emission Tomography for Amyloid Biomarker
Timeframe: One-Time
Fluid Biomarkers
Timeframe: 3 Years
Neuropsychiatric and Neurocognitive Tests
Timeframe: 3 years
Neurological Evaluation
Timeframe: 3 years
Magnetic Resonance Imagining Biomarkers
Timeframe: 3 years
Neuroimaging Positron Emission Tomography for Tau Biomarker
Timeframe: 3 years
Magnetic Resonance Spectroscopy Biomarkers
Timeframe: 3 years